Cargando...
Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy
PURPOSE: To evaluate the effects of metreleptin in patients with partial lipodystrophy (PL). METHODS: Patients aged ≥6 months with PL, circulating leptin <12.0 ng/mL, and diabetes mellitus, insulin resistance, or hypertriglyceridemia received metreleptin doses (once or twice daily) titrated to a...
Gardado en:
| Publicado en: | Endocrine |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7340120/ https://ncbi.nlm.nih.gov/pubmed/30805888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12020-019-01862-8 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|